1
|
Armstrong EP: Prophylaxis of cervical
cancer and related cervical disease: a review of the
cost-effectiveness of vaccination against oncogenic HPV types. J
Manag Care Pharm. 16:217–230. 2010.PubMed/NCBI
|
2
|
Peirson L, Fitzpatrick Lewis D, Ciliska D
and Warren R: Screening for cervical cancer: a systematic review
and meta-analysis. Syst Rev. 2:352013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Priebe AM: 2012 Cervical cancer screening
guidelines and the future role of HPV testing. Clin Obstet Gynecol.
56:44–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Smaniotto D, D'Agostino G, Luzi S, et al:
Concurrent 5-fluorouracil, mitomycin C and radiation with or
without brachytherapy in recurrent cervical cancer: a scoring
system to predict clinical response and outcome. Tumori.
91:295–301. 2005.PubMed/NCBI
|
5
|
Peiretti M, Zapardiel I, Zanagnolo V, et
al: Management of recurrent cervical cancer: a review of the
literature. Surg Oncol. 21:e59–e66. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Elst P, Ahankour F and Tjalma W:
Management of recurrent cervical cancer. Review of the literature
and case report. Eur J Gynaecol Oncol. 28:435–441. 2007.PubMed/NCBI
|
7
|
Morley GW and Seski JC: Radical pelvic
surgery versus radiation therapy for stage I carcinoma of the
cervix (exclusive of microinvasion). Am J Obstet Gynecol.
126:785–798. 1976.PubMed/NCBI
|
8
|
Hopkins MP and Morley GW: Radical
hysterectomy versus radiation therapy for stage IB squamous cell
cancer of the cervix. Cancer. 68:272–277. 1991. View Article : Google Scholar : PubMed/NCBI
|
9
|
Estape RE, Angioli R, Madrigal M, et al:
Close vaginal margins as a prognostic factor after radical
hysterectomy. Gynecol Oncol. 68:229–232. 1998. View Article : Google Scholar : PubMed/NCBI
|
10
|
Mabuchi S, Isohashi F, Yoshioka Y, et al:
Prognostic factors for survival in patients with recurrent cervical
cancer previously treated with radiotherapy. Int J Gynecol Cancer.
20:834–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Scatchard K, Forrest JL, Flubacher M, et
al: Chemotherapy for metastatic and recurrent cervical cancer.
Cochrane Database Syst Rev. 10:CD0064692012.PubMed/NCBI
|
12
|
Tao X, Hu W, Ramirez PT and Kavanagh JJ:
Chemotherapy for recurrent and metastatic cervical cancer. Gynecol
Oncol. 110 (3 Suppl 2):S67–S71. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Moore DH: Chemotherapy for advanced,
recurrent and metastatic cervical cancer. J Natl Compr Canc Netw.
6:53–57. 2008.PubMed/NCBI
|
14
|
Benedet JL, Odicino F, Maisonneuve P, et
al: Carcinoma of the cervix uteri. Int J Gynaecol Obstet. 83
Suppl:1:41–78. 2003. View Article : Google Scholar
|
15
|
Yang YC, Shen J, Tate JE, et al: Cervical
cancer in young women in Taiwan: prognosis is independent of
papillomavirus or tumor cell type. Gynecol Oncol. 64:59–63. 1997.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Cao L, Li X, Zhang Y and Wang Q: Clinical
features and prognosis of cervical cancer in young women. J Central
South Univ (Med Sci). 35:875–878. 2010.
|
17
|
Goncalves A, Fabbro M, Lhomme C, et al: A
phase II trial to evaluate gefitinib as second- or third-line
treatment in patients with recurring locoregionally advanced or
metastatic cervical cancer. Gynecol Oncol. 108:42–46. 2008.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Keys HM, Bundy BN, Stehman FB, et al
Gynecologic Oncology Group: Radiation therapy with and without
extrafascial hysterectomy for bulky stage IB cervical carcinoma: a
randomized trial of the Gynecologic Oncology Group. Gynecol Oncol.
89:343–353. 2003. View Article : Google Scholar : PubMed/NCBI
|
19
|
Cetina L, Garcia-Arias A, Candelaria M, et
al: Brachytherapy versus radical hysterectomy after external beam
chemoradiation: a non-randomized matched comparison in IB2-IIB
cervical cancer patients. World J Surg Oncol. 7:192009. View Article : Google Scholar : PubMed/NCBI
|
20
|
Classe JM, Rauch P, Rodier JF, et al
Groupe des Chirurgiens de Centre de Lutte Contre le Cancer: Surgery
after concurrent chemoradiotherapy and brachytherapy for the
treatment of advanced cervical cancer: morbidity and outcome:
results of a multicenter study of the GCCLCC (Groupe des
Chirurgiens de Centre de Lutte Contre le Cancer). Gynecol Oncol.
102:523–529. 2006. View Article : Google Scholar : PubMed/NCBI
|
21
|
Morice P, Uzan C, Zafrani Y, et al: The
role of surgery after chemoradiation therapy and brachytherapy for
stage IB2/II cervical cancer. Gynecol Oncol. 107 (1 Suppl
1):S122–S124. 2007. View Article : Google Scholar : PubMed/NCBI
|